Epidermolysis Bullosa Dystrophica Clinical Trial
Official title:
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
We will obtain a detailed medical history and will perform a skin examination and brief physical exam. Photographs may be taken. We will ask questions about the size and duration wounds. LAB TESTS We will draw blood to determine overall health status to include Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus (HIV) testing. Genetic testing may also be performed. BIOPSIES Biopsies may be collected to check for Collagen 7 and for antibodies to Collagen 7. Based on the results obtained, it may be possible to identify patients who would qualify to participate in current or future clinical trials. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01263379 -
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
|
Phase 1/Phase 2 | |
Completed |
NCT01716169 -
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
|
N/A | |
Completed |
NCT00951964 -
Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
|
Phase 2 | |
Recruiting |
NCT03269474 -
Computational Drug Repurposing for All EBS Cases
|
||
Completed |
NCT03241628 -
Proof of Concept Study for a Dressing Glove
|
N/A | |
Not yet recruiting |
NCT05390073 -
Growth Hormone in EB
|
||
Recruiting |
NCT04213703 -
A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
|
||
Not yet recruiting |
NCT06177353 -
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
|
||
Recruiting |
NCT06007235 -
CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
|
N/A | |
Active, not recruiting |
NCT05843994 -
Artificial Intelligence Patient App for RDEB SCCs
|
||
Active, not recruiting |
NCT05033574 -
The State of Sexual Development in Children With Inherited Epidermolysis Bullosa
|
||
Completed |
NCT04908215 -
INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa
|
Phase 2 | |
Terminated |
NCT00587223 -
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
|
Phase 3 | |
Active, not recruiting |
NCT04171661 -
Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa
|
Early Phase 1 | |
Terminated |
NCT00533572 -
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
|
N/A | |
Completed |
NCT00904163 -
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
|
N/A | |
Recruiting |
NCT03786237 -
Rigosertib for RDEB-SCC
|
Phase 1/Phase 2 |